Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Natco Pharma USFDA 483:Cleaning deficien

Natco Pharma (india) Kothur facility was inspected by USFDA (Investigators Pratik S. Upadhyay and Saleem

Qvents Team
February 5, 2025

FDA Approves Tarsus’s Lotilaner (XDEMV

Tarsus Pharmaceuticals Inc., in a statement announced FDA approval of Lotilaner ophthalmology solution 0.25% (XDEMVYâ„¢).

Qvents
July 27, 2023